Poseida Therapeutics Presents High-Fidelity Genome Editing System for Production of Allogeneic “Universal Donor … – PR Newswire (press release)
|
Poseida Therapeutics Presents High-Fidelity Genome Editing System for Production of Allogeneic "Universal Donor …
PR Newswire (press release) In a study presented today at the American Society of Clinical Oncology (ASCO) 2017 Annual Meeting, the world's premier oncology event, researchers at Poseida used its proprietary gene editing tools to create a universal donor CAR–T cell therapy that … |
